tradingkey.logo

Biomerica Inc

BMRA

2.880USD

-0.050-1.71%
終値 09/19, 16:00ET15分遅れの株価
7.33M時価総額
損失額直近12ヶ月PER

Biomerica Inc

2.880

-0.050-1.71%
詳細情報 Biomerica Inc 企業名
Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures and markets advanced diagnostic and therapeutic products. Its diagnostic test kits are utilized in the analysis of blood, urine, nasal, or fecal samples for the diagnosis of various diseases, food intolerances, and other medical conditions. Its range of medical diagnostic products is sold primarily in two markets: clinical laboratories and point-of-care settings, including physicians’ offices and over-the-counter sales. It is focused on research and development efforts and is its patented diagnostic-guided therapy (DGT) product, developed on the in Foods technology platform. Its inFoods IBS product, uses a simple blood test to identify patient-specific foods that, when eliminated, may alleviate IBS symptoms such as pain, bloating, diarrhea, cramping, and constipation. Its hp+detect, a new diagnostic test for detecting Helicobacter pylori (H. pylori) bacteria in the gastrointestinal tract.
企業情報
企業コードBMRA
会社名Biomerica Inc
上場日Mar 17, 1980
最高経営責任者「CEO」Mr. Zackary S. Irani
従業員数53
証券種類Ordinary Share
決算期末Mar 17
本社所在地17571 Von Karman Avenue
都市IRVINE
証券取引所NASDAQ Capital Market Consolidated
United States of America
郵便番号92614
電話番号19493792875
ウェブサイトhttps://biomerica.com/
企業コードBMRA
上場日Mar 17, 1980
最高経営責任者「CEO」Mr. Zackary S. Irani
役員一覧
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Zackary S. Irani
Mr. Zackary S. Irani
Chief Executive Officer, Director
Chief Executive Officer, Director
158.82K
+24.50%
Mr. Gary Lu
Mr. Gary Lu
Chief Financial Officer
Chief Financial Officer
19.38K
--
Mr. David Moatazedi
Mr. David Moatazedi
Independent Director
Independent Director
10.63K
--
Mr. Eric Chin
Mr. Eric Chin
Independent Director
Independent Director
10.00K
--
Mr. Scott Madel
Mr. Scott Madel
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Allen C. Barbieri
Mr. Allen C. Barbieri
Executive Vice Chairperson of the Board and Corporate Secretary
Executive Vice Chairperson of the Board and Corporate Secretary
--
--
Dr. Jane F. Emerson, M.D., Ph.D.
Dr. Jane F. Emerson, M.D., Ph.D.
Independent Director
Independent Director
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Zackary S. Irani
Mr. Zackary S. Irani
Chief Executive Officer, Director
Chief Executive Officer, Director
158.82K
+24.50%
Mr. Gary Lu
Mr. Gary Lu
Chief Financial Officer
Chief Financial Officer
19.38K
--
Mr. David Moatazedi
Mr. David Moatazedi
Independent Director
Independent Director
10.63K
--
Mr. Eric Chin
Mr. Eric Chin
Independent Director
Independent Director
10.00K
--
Mr. Scott Madel
Mr. Scott Madel
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Allen C. Barbieri
Mr. Allen C. Barbieri
Executive Vice Chairperson of the Board and Corporate Secretary
Executive Vice Chairperson of the Board and Corporate Secretary
--
--
収益内訳
通貨: USD更新時刻: Sun, Jul 6
通貨: USD更新時刻: Sun, Jul 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
事業別USD
会社名
収益
比率
Clinical Lab
627.00K
56.03%
Contract Manufacturing
320.00K
28.60%
OTC
170.00K
15.19%
Physicians’ Office
2.00K
0.18%
地域別USD
会社名
収益
比率
United States
404.00K
36.10%
Asia
365.00K
32.62%
Europe
198.00K
17.69%
Middle East
149.00K
13.32%
South America
3.00K
0.27%
事業別
地域別
事業別USD
会社名
収益
比率
Clinical Lab
627.00K
56.03%
Contract Manufacturing
320.00K
28.60%
OTC
170.00K
15.19%
Physicians’ Office
2.00K
0.18%
株主
更新時刻: Mon, Sep 8
更新時刻: Mon, Sep 8
株主統計
種類
株主統計
株主統計
比率
Irani (Zackary S)
5.64%
Barbieri (Allen)
0.84%
Geode Capital Management, L.L.C.
0.77%
The Vanguard Group, Inc.
0.75%
Potomac Capital Management Inc.
0.74%
他の
91.26%
株主統計
株主統計
比率
Irani (Zackary S)
5.64%
Barbieri (Allen)
0.84%
Geode Capital Management, L.L.C.
0.77%
The Vanguard Group, Inc.
0.75%
Potomac Capital Management Inc.
0.74%
他の
91.26%
種類
株主統計
比率
Individual Investor
9.16%
Investment Advisor
1.63%
Investment Advisor/Hedge Fund
0.84%
Hedge Fund
0.74%
他の
87.63%
機関投資家保有株
更新時刻: Tue, Jul 1
更新時刻: Tue, Jul 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q2
71
405.55K
15.93%
-188.61K
2025Q1
76
410.80K
15.63%
-250.78K
2024Q4
75
3.95M
21.57%
-995.41K
2024Q3
72
3.29M
19.49%
-2.27M
2024Q2
72
4.09M
24.25%
-2.17M
2024Q1
69
5.91M
35.06%
-122.92K
2023Q4
64
5.72M
33.95%
-599.64K
2023Q3
64
6.05M
35.94%
-733.42K
2023Q2
65
6.44M
38.42%
-719.23K
2023Q1
74
6.78M
42.10%
-508.01K
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Irani (Zackary S)
158.82K
6.24%
+31.25K
+24.50%
Dec 13, 2024
Barbieri (Allen)
23.54K
0.92%
+13.75K
+140.42%
Dec 13, 2024
Geode Capital Management, L.L.C.
19.57K
0.77%
+4.76K
+32.13%
Mar 31, 2025
The Vanguard Group, Inc.
21.13K
0.83%
--
--
Mar 31, 2025
Potomac Capital Management Inc.
20.96K
0.82%
-477.00
-2.22%
Dec 31, 2023
Emerson (Jane)
19.50K
0.77%
+10.63K
+119.72%
Dec 13, 2024
Lu (Gary)
19.38K
0.76%
+19.38K
--
Dec 13, 2024
BlackRock Institutional Trust Company, N.A.
18.64K
0.73%
--
--
Mar 31, 2025
Coste (Catherine)
16.10K
0.63%
+10.63K
+194.10%
Dec 13, 2024
Moatazedi (David)
10.63K
0.42%
+10.63K
--
Dec 13, 2024
詳細を見る
関連ETF
銘柄名
比率
データなし
配当金
過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
データなし
日付
種類
比率
データなし
KeyAI